Petros Pharmaceuticals Inc (PTPI) Down 12.14% in Premarket Trading

Petros Pharmaceuticals Inc (PTPI) is lower by Thursday morning, with the stock losing -12.14% in pre-market trading to 3.33. PTPI's short-term technical score of 78 indicates that the stock has traded more bullishly over the last month than 78% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 136 out of 146 industries, PTPI ranks higher than 94% of stocks. Petros Pharmaceuticals Inc has risen 77.10% over the past month, closing at $2.61 on June 15. During this period of time, the stock fell as low as $1.81 and as high as $2.89.

PTPI has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on PTPI!

See Full PTPI Report

Petros Pharmaceuticals Inc has a Long-Term Technical rank of 71. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 29% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 136 by this metric, PTPI ranks better than 136% of stocks.

Important Dates for Investors in PTPI:

-Petros Pharmaceuticals Inc is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $-11.10. -We do not have a set dividend date for Petros Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Petros Pharmaceuticals Inc (PTPI)